Reproductive Endocrinology · Luteal Phase

Outcome of progesterone treatment of luteal phase inadequacy

Wentz AC, Herbert CM, Maxson WS, Garner CH

Published June 1984 Fertility and Sterility, 41(6), 856-862
DOI 10.1016/s0015-0282(16)47898-2 PMID 6724001

RRM Academy Synopsis

Progesterone-treated luteal phase inadequacy ended in 19 deliveries

Among 79 women in a 1984 chart review, 54 on progesterone suppositories alone had 23 pregnancies and 19 deliveries. All had luteal phase inadequacy.

Key Findings

  • Diagnosis needed a biopsy over 2 days out of phase in two cycles, or one in high-risk women. Forty-five of 50 (90%) repeat biopsies were out of phase.
  • Progesterone suppositories alone: 54 women, 23 pregnancies, 19 deliveries. Clomiphene citrate alone: 6 women, 2 pregnancies and deliveries. Combined treatment: 7 women, 5 pregnancies, 4 deliveries.
  • Among 45 women who had a biopsy during treatment, 37 of 45 (82%) showed an in-phase biopsy. In 7 of 45 (16%), the defect was not corrected.
  • Among 38 women with two out-of-phase biopsies who took progesterone alone, 16 pregnancies were documented, 14 during treatment. Twelve of 14 delivered.
  • Among 20 women with a history of early pregnancy loss, 8 of 10 (80%) treated with progesterone delivered.

Interpretation

The study is a retrospective chart review from one center. Follow-up was mostly by telephone survey and was missing for seven women. The review had no control group and no randomization, so it cannot show that progesterone caused the deliveries. Eight women went untreated, and the authors did not analyze them as a comparison. The authors did not analyze failure to conceive, because many women also had endometriosis, pelvic adhesions, cervical factor or male factor. Treatment followed the suspected cause, so the arms differ by design. The authors call the results a trend and write that numbers in the pregnancy-loss subgroup were too low to conclude progesterone helped.

RRM Context

The authors looked for other treatable causes first. They matched treatment to the suspected cause. Women with thyroid or prolactin problems were treated for those and left out. Women with long follicular phases received clomiphene citrate. This follows the restorative reproductive medicine principle of evaluation before treatment. The paper also lists male factor among other diagnoses that can coexist.

Abstract

Diagnosis, choice of therapy, and pregnancy outcome were analyzed in 79 women evaluated for luteal phase inadequacy. Criteria for the diagnosis were established, and groups at risk for luteal inadequacy were identified. Treatment choices, tailored to the suspected cause, included progesterone suppositories in 54 women, with 23 pregnancies and 19 deliveries; clomiphene citrate in 6 women, with 2 pregnancies and deliveries; and combined treatment in 7 women, with 5 pregnancies and 4 deliveries. Eight women received no treatment, including three who underwent endometrial biopsy in the cycle of conception and who subsequently delivered. These data suggest that careful diagnosis and the proper choice of treatment are important, and that progesterone supplementation may result in improved pregnancy outcome for patients with infertility and pregnancy wastage who have luteal phase inadequacy.

Topics

By this author

Related research

Reproductive Endocrinology › Luteal Phase › Luteal Phase Deficiency · Infertility › Luteal Phase Defect › Progesterone Replacement · Menstrual Cycle › Cycle Disorders › Ovulatory Disturbances
Anne Colston Wentz, Carl M. Herbert, Wayne S. Maxson, Catherine H. Garner
A Wentz, C Herbert, W Maxson, Cathy Garner, Kate Garner, C Garner
PMID 6724001 6724001 DOI 10.1016/s0015-0282(16)47898-2 10.1016/s0015-0282(16)47898-2 Wentz et al. 1984, Wentz 1984